- Home
- XENE
as 05-30-2025 11:44am EST
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
| Founded: | 1996 | Country: | Canada |
| Employees: | N/A | City: | BURNABY |
| Market Cap: | 2.5B | IPO Year: | 2014 |
| Target Price: | $54.82 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.22 | EPS Growth: | N/A |
| 52 Week Low/High: | $26.74 - $46.00 | Next Earning Date: | 05-12-2025 |
| Revenue: | $7,500,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 611.23% |
Latest Xenon Pharmaceuticals Inc. News
XENE Breaking Stock News: Dive into XENE Ticker-Specific Updates for Smart Investing
GlobeNewswire
16 days ago
Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference
Insider Monkey
16 days ago
Why Xenon Pharmaceuticals Inc. (XENE) Declined on Tuesday
Zacks
17 days ago
Xenon Q1 Loss Narrower Than Expected, Pipeline Development in Focus
MT Newswires
17 days ago
RBC Adjusts Price Target on Xenon Pharmaceuticals to $55 From $58, Maintains Outperform Speculative Risk Rating
GuruFocus.com
17 days ago
Xenon Pharmaceuticals Inc (XENE) Q1 2025 Earnings Call Highlights: Strong Financial Position ...
MT Newswires
18 days ago
Xenon Pharmaceuticals Q1 Loss Widens; Shares Drop
Associated Press Finance
18 days ago
Xenon Pharmaceuticals: Q1 Earnings Snapshot
GlobeNewswire
18 days ago
Xenon Reports First Quarter 2025 Financial Results and Provides Business Update
Compare XENE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "XENE Xenon Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.